212 related articles for article (PubMed ID: 26948831)
1. A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.
Kantarci FE; Eren R; Gündoğan C; Huq GE; Doğu MH; Suyanı E
J Infect Chemother; 2016 Jul; 22(7):483-5. PubMed ID: 26948831
[TBL] [Abstract][Full Text] [Related]
2. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
Murphy C; Hawkes E; Chionh F; Chong G
J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
[TBL] [Abstract][Full Text] [Related]
3. Human herpesvirus 8-related Castleman disease in the absence of HIV infection.
Dossier A; Meignin V; Fieschi C; Boutboul D; Oksenhendler E; Galicier L
Clin Infect Dis; 2013 Mar; 56(6):833-42. PubMed ID: 23223599
[TBL] [Abstract][Full Text] [Related]
4. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated multicentric Castleman disease.
Oksenhendler E
Curr Opin HIV AIDS; 2009 Jan; 4(1):16-21. PubMed ID: 19343828
[TBL] [Abstract][Full Text] [Related]
6. Post-liver transplantation multicentric Castleman disease treated with valganciclovir and weaning of immunosuppression.
Lim EJ; Crowley P; Mitchell CA; Angus PW
Am J Transplant; 2011 Jan; 11(1):169-72. PubMed ID: 21199357
[TBL] [Abstract][Full Text] [Related]
7. [A Japanese case of human herpes virus-8-associated multicentric castleman disease complicated by hemophagocytic syndrome].
Miyagi T; Nagasaki A; Taira T; Yamanoha A; Taira N; Aonahata M; Yoshimi N; Ohshima K; Takasu N
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1431-4. PubMed ID: 18701866
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
10. Multicentric Castleman's disease treated with antivirals and immunosuppressants.
Senanayake S; Kelly J; Lloyd A; Waliuzzaman Z; Goldstein D; Rawlinson W
J Med Virol; 2003 Nov; 71(3):399-403. PubMed ID: 12966545
[TBL] [Abstract][Full Text] [Related]
11. The incidence of human herpes virus-8 expression in lymph node biopsies from human immunodeficiency virus-positive patients.
Beukes CA; Thiart J
Histopathology; 2012 Nov; 61(5):942-4. PubMed ID: 22716315
[TBL] [Abstract][Full Text] [Related]
12. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
[TBL] [Abstract][Full Text] [Related]
13. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.
Casper C; Nichols WG; Huang ML; Corey L; Wald A
Blood; 2004 Mar; 103(5):1632-4. PubMed ID: 14615380
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection: A case report.
Guayboon T; Chinthammitr Y; Sukpanichnant S; Horthongkham N; Angkasekwinai N
Medicine (Baltimore); 2021 Dec; 100(49):e28077. PubMed ID: 34889256
[TBL] [Abstract][Full Text] [Related]
15. An HHV-8 Positive HIV Negative Multicentric Castleman's Disease, who Responded well to Rituximab Alone.
Kounatidis D; Rontogianni D; Sampaziotis D; Vardaka M; Giatra C; Dolapsakis C; Margellou E; Vallianou NG
Cardiovasc Hematol Disord Drug Targets; 2020; 20(1):84-86. PubMed ID: 30827270
[TBL] [Abstract][Full Text] [Related]
16. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
[TBL] [Abstract][Full Text] [Related]
17. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
[TBL] [Abstract][Full Text] [Related]
19. Complete remission in a patient with human herpes virus-8 negative multicentric Castleman disease using CHOP chemotherapy.
Seo HY; Kim EB; Kim JW; Shin BK; Kim SJ; Kim BS
Cancer Res Treat; 2009 Jun; 41(2):104-7. PubMed ID: 19707509
[TBL] [Abstract][Full Text] [Related]
20. Human herpes virus-8-associated multicentric Castleman's disease in an HIV-positive patient presenting with relapsing and remitting hyponatraemia.
Sasaki H; Maeda T; Hara Y; Osa M; Imai K; Moriguchi K; Mikita K; Fujikura Y; Kaida K; Kawana A
Int J STD AIDS; 2015 Oct; 26(12):909-11. PubMed ID: 25504830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]